Uberto Fumagalli Romario
Overview
Explore the profile of Uberto Fumagalli Romario including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
505
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pelc Z, Sedlak K, Endo Y, Van Sandick J, Gisbertz S, Pera M, et al.
Am J Surg
. 2025 Feb;
242:116235.
PMID: 39954554
Introduction: Palliative chemotherapy is the current standard among advanced gastric cancer (GC) patients with peritoneal metastasis (PM), while the role of gastrectomy with cytoreductive surgery and HIPEC remains unclear. The...
2.
Danieli M, Romario U, Radice D, Pozzi S, Spada F, Funicelli L, et al.
Ann Surg Oncol
. 2024 Dec;
32(3):2189-2190.
PMID: 39725748
No abstract available.
3.
Gambella A, Fiocca R, Lugaresi M, DErrico A, Malvi D, Spaggiari P, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682231
The Esophageal Adenocarcinoma Study Group Europe (EACSGE) recently proposed a granular histologic classification of esophageal-esophago-gastric junctional adenocarcinomas (EA-EGJAs) based on the study of naïve surgically resected specimens that, when combined...
4.
Carbone F, Spinelli A, Ciardiello D, Realis Luc M, De Pascale S, Bertani E, et al.
Eur J Cancer
. 2024 Dec;
215:115172.
PMID: 39681013
Background: In the last years, a dramatic increase in colorectal cancer (CRC) diagnoses in early-onset (EO) patients has been observed. The prognosis of EO-CRC compared to late-onset (LO) patients is...
5.
Danieli M, Romario U, Radice D, Pozzi S, Spada F, Funicelli L, et al.
Ann Surg Oncol
. 2024 Dec;
32(3):2141-2149.
PMID: 39627636
Background: The role of prophylactic primary tumor resection (PTR) in patients with small intestinal neuroendocrine tumors (SI-NETs) and unresectable liver metastases is a matter of debate. Objective: We aimed to...
6.
Sofia S, Degiuli M, Anania G, Baiocchi G, Baldari L, Baldazzi G, et al.
J Clin Med
. 2024 Aug;
13(16).
PMID: 39200831
: The textbook outcome (TO) is a composite tool introduced to uniform surgical units and regulate surgical quality and outcomes. A patient is considered TO only if all predetermined items...
7.
Dal Cero M, Gibert J, Grande L, Gimeno M, Osorio J, Bencivenga M, et al.
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001525
Background: Radical gastrectomy remains the main treatment for gastric cancer, despite its high mortality. A clinical predictive model of 90-day mortality (90DM) risk after gastric cancer surgery based on the...
8.
Gervaso L, Ciardiello D, Gregato G, Guidi L, Valenza C, Ascione L, et al.
Ther Adv Med Oncol
. 2024 Jun;
16:17588359241249602.
PMID: 38882445
Background: The management of locally advanced rectal cancer (LARC) relies on a multimodal approach. Neither instrumental work-up nor molecular biomarkers are currently available to identify a risk-adapted strategy. Objectives: We...
9.
Pelc Z, Sedlak K, Lesniewska M, Mielniczek K, Chawrylak K, Skorzewska M, et al.
Cancers (Basel)
. 2024 May;
16(9).
PMID: 38730672
The incidence of gastric cancer (GC) is expected to increase to 1.77 million cases by 2040. To improve treatment outcomes, GC patients are increasingly treated with neoadjuvant chemotherapy (NAC) prior...
10.
Bertani E, Mattana F, Collamati F, Ferrari M, Bagnardi V, Frassoni S, et al.
Ann Surg Oncol
. 2024 May;
31(7):4199-4200.
PMID: 38722424
No abstract available.